Sort   by:  
 Page size 
UnknownA two-level multimodality imaging Bayesian network approach for classification of partial epilepsy: preliminary data.
Not available
S-EPMC3619666 | biostudies-literature
UnknownValidation of 3- and 5-point severity scales to assess ARIA-E.
Not available
S-EPMC10667607 | biostudies-literature
UnknownARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease.
Not available
S-EPMC10026083 | biostudies-literature
UnknownComparing ARIA-E severity scales and effects of treatment management thresholds.
Not available
S-EPMC9716634 | biostudies-literature
UnknownAmyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis.
Not available
S-EPMC4717448 | biostudies-literature
UnknownEvaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
Not available
S-EPMC8609885 | biostudies-literature
UnknownAmyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease.
Not available
S-EPMC8609465 | biostudies-literature
UnknownA phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
Not available
S-EPMC2790221 | biostudies-literature
UnknownHippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials.
Not available
S-EPMC12855230 | biostudies-literature
UnknownAlzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities.
Not available
S-EPMC11735439 | biostudies-literature
Sort   by:  
 Page size